What is CAR T-Cell Therapy?

Wednesday, May 9, 2018 - 10:04am

We’re entering a hopeful new era with the development of immunotherapies, which use the power of your own immune system to fight cancer. Immunotherapies can produce long-term remissions and are generally associated with side effects that are milder than those caused by chemotherapy. They also have the potential to work even when chemotherapy and radiation have failed.

You may have heard about Chimeric Antigen Receptor (CAR) T-cell therapy, one of several types of immunotherapy available at Roswell Park. The video above explains how CAR T-cell therapy works.

Roswell Park offers both FDA-approved CAR T-cell therapies — Yescarta, for adult patients with large B-cell lymphoma, and Kymriah, for patients 25 and younger with acute lymphoblastic leukemia (ALL) and also for adults with large B-cell lymphoma. We also offer clinical trials of other CAR T-cell therapies and advanced T-cell receptor (TCR) therapies developed right here to treat virtually any type of cancer.

Want to know more? Here’s the full menu of the types of immunotherapy offered at Roswell Park.

Never miss another Cancer Talk blog!
Sign up to receive our monthly Cancer Talk e-newsletter.

Sign up!